Segall Bryant & Hamill Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EQC
Equity Commonwealth
EQC
|
+$114M |
| 2 |
S&P Global
SPGI
|
+$51.7M |
| 3 |
SPDR Gold Trust
GLD
|
+$41.9M |
| 4 |
Mercury Systems
MRCY
|
+$40.7M |
| 5 |
Cousins Properties
CUZ
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$56.5M |
| 2 |
Regal Rexnord
RRX
|
+$38.6M |
| 3 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
+$38.2M |
| 4 |
Coty
COTY
|
+$27.2M |
| 5 |
Adobe
ADBE
|
+$21.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.92% |
| 2 | Healthcare | 16.37% |
| 3 | Industrials | 14.46% |
| 4 | Financials | 12.71% |
| 5 | Consumer Discretionary | 9.42% |
Similar funds
Segall Bryant & Hamill's Q1 2022 Portfolio in Review
As of Q1 2022, Segall Bryant & Hamill held 778 positions worth $10.5B, down 3.4% from $10.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Segall Bryant & Hamill deployed $445M of net new capital in Q1 2022, opening 182 new positions and adding to 221 existing holdings. Its largest new stake was Equity Commonwealth: 4,257,427 shares worth $120M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Regal Rexnord, an estimated $38.6M trimmed.
- Segall Bryant & Hamill's largest Q1 2022 buy was Equity Commonwealth: 4,257,427 shares worth $120M.
- Segall Bryant & Hamill added most to S&P Global in Q1 2022, an estimated $51.7M increase.
- Segall Bryant & Hamill's biggest Q1 2022 reduction was Regal Rexnord, cutting an estimated $38.6M.
- Segall Bryant & Hamill fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $56.5M.
- Segall Bryant & Hamill's ten largest holdings make up 17% of its $10.5B portfolio in Q1 2022.
- Segall Bryant & Hamill opened 182 new positions and closed 35 in Q1 2022.
- Segall Bryant & Hamill's portfolio value fell 3.4% quarter-over-quarter to $10.5B.
Based on Segall Bryant & Hamill's 13F filing for Q1 2022, filed 13 May 2022.